
    
      Following completion of the NS2014-1 final study visit procedures, Subjects will be offered
      the opportunity to enroll in this longitudinal observational cohort protocol to monitor their
      depression and to assess durability of effect and long-term safety of NSI-189.

      The Enrollment Visit begins when informed consent is signed.The duration of the follow-up
      period will be up to 6 months, until the start of a new antidepressant treatment. Subjects
      who provide consent will be seen for in-person visits every 8 weeks, with bi-monthly phone
      visits occurring between in-person visits. Safety assessments and efficacy assessments will
      be performed at each visit. No study drug will be taken during the Longitudinal Observational
      Cohort study.
    
  